200 results
8-K
EX-10.1
MRZM
Marizyme, Inc.
21 Nov 23
Entry into a Material Definitive Agreement
4:15pm
or failed to make any statement that would reasonably be expected to provide a basis for the FDA to invoke its policy with respect to “Fraud, Untrue … (42 U.S.C. § 1320a-7b(a)), all criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286 and 287
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
to prevent fraud. Failure to report its financial information on an accurate or timely basis may thereby subject the Company to adverse regulatory … prevent financial fraud. If we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed, investors
8-K
EX-10.1
6aqsvmaf3rbyqdh2n9
5 Sep 23
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
g52xft eq
12 Jul 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cd6pe9ivntwbynw 6s
5 Jun 23
Entry into a Material Definitive Agreement
4:19pm
D
yir1a5t4m iia
19 May 23
$10.00 mm in equity / options / securities to be acquired, sold $1.00 mm, 1 investor
8:47am
8-K
EX-10.1
yb9xxbv
18 May 23
Entry into a Material Definitive Agreement
5:29pm
D
dacl49 fbye
10 May 23
$265.22 k in equity / options / securities to be acquired, sold $265.22 k, 4 investors
2:17pm